Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial

The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in the treatment of COVID-19. This was a randomized, controlled, single-center, open-label trial (NCT04854941). Inpatients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivashkin, Vladimir, Fomin, Victor, Moiseev, Sergey, Brovko, Michail, Maslennikov, Roman, Ulyanin, Anatoly, Sholomova, Victoria, Vasilyeva, Maria, Trush, Elizaveta, Shifrin, Oleg, Poluektova, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512595/
https://www.ncbi.nlm.nih.gov/pubmed/34643888
http://dx.doi.org/10.1007/s12602-021-09858-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512595/
https://www.ncbi.nlm.nih.gov/pubmed/34643888
http://dx.doi.org/10.1007/s12602-021-09858-5

Ejemplares similares